Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Terumo Corporation
  6. Summary
    4543   JP3546800008

TERUMO CORPORATION

(4543)
  Report
Delayed Japan Exchange  -  12:09 2022-07-07 am EDT
4212.00 JPY   +2.76%
07/06Japanese shares track Wall Street higher, tech stocks lead gains
RE
07/05Orchestra BioMed, Inc. announced that it has received $110.000003 million in funding from Medtronic plc, RTW Investments, LP, SternAegis Ventures, Terumo Corporation, Perceptive Advisors LLC, and other investors
CI
07/04TERUMO : Aortic Announces First Commercial Implant of the Thoraflex Hybrid Device in the United States
PU
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Japan Exchange
07/01/2022 07/04/2022 07/05/2022 07/06/2022 07/07/2022 Date
4013(c) 4062(c) 4100(c) 4099(c) 4212 Last
1 624 400 1 034 600 1 271 500 1 706 500 1 350 500 Volume
-1.83% +1.22% +0.94% -0.02% +2.76% Change
More quotes
Estimated financial data (e)
Sales 2023 774 B 5 701 M 5 701 M
Net income 2023 102 B 750 M 750 M
Net cash position 2023 19 453 M 143 M 143 M
P/E ratio 2023 30,2x
Yield 2023 0,90%
Sales 2024 829 B 6 108 M 6 108 M
Net income 2024 117 B 864 M 864 M
Net cash position 2024 82 714 M 609 M 609 M
P/E ratio 2024 26,1x
Yield 2024 0,98%
Capitalization 3 100 B 22 832 M 22 832 M
EV / Sales 2023 3,98x
EV / Sales 2024 3,64x
Nbr of Employees 28 294
Free-Float 95,3%
More Financials
Company
Terumo Corporation specializes in the design, manufacturing and marketing of medical products and equipments. Net sales break down by family of products as follows: - cardiac surgery devices (53.5%); - medical products for hospitals (28.6%): medical devices, nutritional additives, oxygen, medical measuring devices (thermometers, tensiometers, glucometers, etc.), etc.; - sanguine transfusion equipments... 
Read more
More about the company
Ratings of Terumo Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
A-
More Ratings
All news about TERUMO CORPORATION
07/06Japanese shares track Wall Street higher, tech stocks lead gains
RE
07/05Orchestra BioMed, Inc. announced that it has received $110.000003 million in funding fr..
CI
07/04TERUMO : Aortic Announces First Commercial Implant of the Thoraflex Hybrid Device in the U..
PU
07/04TERUMO : Notification Regarding Status of Acquisition of the Company's Own Shares
PU
07/04Tranche Update on Terumo Corporation's Equity Buyback Plan announced on May 12, 2022.
CI
06/28Terumo Blood and Cell Technologies and GenCure collaborate to advance cell and gene the..
AQ
06/23TERUMO : Plasma Innovation Business Seminar (PDF 3.62 MB)
PU
06/22TERUMO : Announces Voting Results for the Election of Directors (PDF 90.72 KB)
PU
06/17TERUMO : NHS England Chooses Spectra Optia® Apheresis System as Part of MedTech Funding Ma..
PU
06/16NHS England chooses Spectra Optia(R) Apheresis System as part of MedTech Funding Mandat..
AQ
06/15TERUMO : Holmium-166 SIRT Demonstrates Safety and Efficacy in the Treatment of Hepatocellu..
PU
06/06TERUMO : Appoints Three Associates as the Newest Terumo Fellow
PU
06/03TERUMO : Radboudumc and Terumo Europe N.V. Sign Collaboration Agreement
PU
06/02TERUMO : Notification Regarding Status of Acquisition of the Company's Own Shares (PDF 103..
PU
06/02Diabeloop SAS announced that it has received €70 million in funding from a group o..
CI
More news
News in other languages on TERUMO CORPORATION
05/16Terumo annonce un changement d'indication pour le système CGM Dexcom G6 au Japon
05/13Terumo déclare un dividende plus élevé alors que le bénéfice attribuable de l'exercice ..
05/12TERUMO CORPORATION (TSE : 4543) annonce un rachat d'actions pour 15.000.000 d'actions, rep..
05/12Terumo Corporation fournit des prévisions de dividendes pour l'exercice complet se term..
05/12Terumo Corporation fournit des prévisions de bénéfices consolidés pour l'exercice fisca..
More news
Analyst Recommendations on TERUMO CORPORATION
More recommendations
Stock Trading Strategies
TERUMO CORPORATION - 2021
Big comeback of buyers
BUY
More Stock Trading Analysis
Chart TERUMO CORPORATION
Duration : Period :
Terumo Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TERUMO CORPORATION
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 14
Last Close Price 4 099,00 JPY
Average target price 5 037,14 JPY
Spread / Average Target 22,9%
EPS Revisions
Managers and Directors
Shinjiro Sato Senior Executive Officer
Naoki Muto Chief Financial & Accounting Officer
Toshiaki Takagi Chairman
Katsuya Takeuchi Chief Information Officer & Executive Officer
Kazuhisa Senshu Chief Clinical & Regulatory Affairs Officer
Sector and Competitors
1st jan.Capi. (M$)
TERUMO CORPORATION-15.64%22 841
ABBOTT LABORATORIES-22.77%191 378
MEDTRONIC PLC-13.37%120 235
BECTON, DICKINSON AND COMPANY0.21%70 676
BAXTER INTERNATIONAL INC.-24.15%32 926
HOYA CORPORATION-31.18%31 359